DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications

The marked heterogeneity of lung adenocarcinoma (LUAD) makes its diagnosis and treatment difficult. In addition, the aberrant DNA methylation profile contributes to tumor heterogeneity and alters the immune response. We used DNA methylation array data from publicly available databases to establish a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Aging (Albany NY)
Auteurs principaux: Xu, Feng, He, Lulu, Zhan, Xueqin, Chen, Jiexin, Xu, Huan, Huang, Xiaoling, Li, Yangyi, Zheng, Xiaohe, Lin, Ling, Chen, Yongsong
Format: Artigo
Langue:Inglês
Publié: Impact Journals 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803536/
https://ncbi.nlm.nih.gov/pubmed/33234739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.104129
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires